Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 325
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06942156 | Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in Korea | ||
| NCT02047175 | CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin) | ||
| NCT07358156 | A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and EU-Dupixent® in Healthy Adult Participants. | ||
| NCT02894541 | Study to Investigate the Effects of Food on the Pharmacokinetics/Pharmacodynamics of CKD-519 | ||
| NCT07770737 | Cardioprotective Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Korean Patients With Type 2 Diabetes | ||
| NCT03762369 | A Clinical Study to Evaluate the Efficacy and Safety of CKD-351 | ||
| NCT03646799 | Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D484 in Healthy Adults | ||
| NCT06709807 | Clinical Study to Evaluate the Food Effect of CKD-378 in Healthy Volunteers | ||
| NCT03849339 | Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 Under Fed Condition | ||
| NCT01426100 | CKD-828 Telmisartan Non-Responder Trial | ||
| NCT06627322 | A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH) | ||
| NCT02007941 | Comparative Evaluation of Pharmacokinetics After CKD-501 Between Renal Impaired and Normal Renal Function Subjects | ||
| NCT06838286 | Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes | ||
| NCT04768673 | A Study to Investigate the PK and Safety of CKD-393 | ||
| NCT02645890 | Study to Compare the Safety and Pharmacokinetics of CKD-397 | ||
| NCT03569579 | CKD-355 Drug-drug Interaction Study (CKD-355 DDI P1) | ||
| NCT05952219 | Study to Evaluate the Safety and Pharmacokinetics of CKD-379 | ||
| NCT02827890 | CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1) | ||
| NCT03346187 | A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337 | ||
| NCT02854748 | Evaluate the Drug-drugs Interaction Between Lobeglitazone and Empagliflozin | ||
| NCT03211143 | A Study to Compare PK, PD and Safety of CKD-381 in Healthy Subjects | ||
| NCT01106131 | Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to Metformin | ||
| NCT02498509 | Clinical Trial to Evaluate the Efficacy and Safety of CKD-342 | ||
| NCT02565368 | A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.5/1000 mg in Healthy Male Volunteers | ||
| NCT04255589 | A Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 | ||
| NCT03627182 | Efficacy and Safety of CKD-501 Added to D150 Plus D745 25mg Therapy in Patients With Type 2 Diabetes | ||
| NCT05834595 | A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 | ||
| NCT03536780 | Avelumab in Combination With Gemcitabine in Advanced Leiomyosarcoma as a Second-line Treatment | ||
| NCT03802162 | A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355 | ||
| NCT03849261 | Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy Adults | ||
| NCT06695598 | Clinical Study to Evaluate the Food Effect of CKD-383 0.5/25/1000mg in Healthy Volunteers | ||
| NCT05673369 | Clinical Study to Evaluate Pharmacokinetic Profiles and Safety of CKD-387 Under Fasting Condition | ||
| NCT07215637 | Phase Ia/Ib Study of CKD-512 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Solid Tumors | ||
| NCT05552495 | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-386 in Healthy Volunteers Under Fasting Conditions | ||
| NCT06695572 | Clinical Study to Evaluate the Food Effect of CKD-383 0.5/10/1000mg in Healthy Volunteers | ||
| NCT04987970 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg | ||
| NCT04345796 | Pharmacological Reduction of Right Ventricular Enlargement | ||
| NCT05189288 | Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388(2) in Healthy Subjects | ||
| NCT01766518 | The Study to Evaluate Efficacy and Safety of MY-REPT Capsule in Primary, Liver Transplantation Recipients (MYLT1) | ||
| NCT01663038 | Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination | ||
| NCT05108038 | A Study to Evaluate the PK, PD and Safety of CKD-382 in Healthy Subjects | ||
| NCT05921435 | Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D958 in Healthy Adults | ||
| NCT02002611 | Drug-drug Interaction Study(Lobeglitazone, Warfarin) | ||
| NCT01297036 | Pharmacokinetic Comparisons of Two Donepezil Formulations | ||
| NCT02588937 | Active Drug Comparative Trial to Evaluate the Antiviral Activity and Safety in Chronic Hepatitis B Patients | ||
| NCT03431623 | CKD-11101 Phase 3 SC Study | ||
| NCT04083846 | Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed) | ||
| NCT04102943 | Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients. | ||
| NCT05347576 | A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions | ||
| NCT01369472 | Evaluating Dose-proportionality of Dilatrend Suspended-Release Capsule |
